Hjem › Akut lymfoblastisk leukæmi › Washington › Spokane
Akut lymfoblastisk leukæmi kliniske forsøg i Spokane, WA
3 studier for Akut lymfoblastisk leukæmi søger deltagere på steder i og omkring Spokane (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruttererObservationsstudie
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Akut lymfoblastisk leukæmi forsøg i andre byer
- Houston, TX28 studier
- New York City, NY24 studier
- Baldwin Park, CA21 studier
- Seattle, WA21 studier
- Chicago, IL19 studier
- Atlanta, GA19 studier
- Philadelphia, PA16 studier
- Memphis, TN16 studier
- Washington, DC16 studier
- Boston, MA15 studier
- Los Angeles, CA14 studier
- Durham, NC13 studier
Andre studier i Spokane
- Ikke-småcellet lungecancer12 studier
- Brystkræft8 studier
- Ægstockræft8 studier
- Colorektal kræft8 studier
- Parkinsons sygdom7 studier
- Prostatakræft6 studier
- Kronisk lymfatisk leukæmi6 studier
- Pladecellekræft i hoved og hals6 studier
- Kræft (alle typer)6 studier
- Tripelnegativ brystkræft5 studier
- Melanom5 studier
- Makuladegeneration5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.